Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2027

• 1 Not started
• 78 Active
• 356 Finished

Grants per year

Search results

• Multidisciplinary Clinical Research Center in Rheumatology - Administrative Core

  Pope, R. M., Chang, R. W., Dunlop, D. D., Ramsey-Goldman, R. & Sharma, L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/15/02 → 12/31/07

  Project: Research project

  • Interdisciplinary Research 100%
  • Rheumatology 49%
  • Arthritis 34%
  • Musculoskeletal Diseases 26%
  • Data Management 26%

• Multidisciplinary Clinical Research Center in Rheumatology - Methodology Core

  Chang, R. W., Dunlop, D. D., Dyer, A. R., Pope, R. M. & Ramsey-Goldman, R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/15/02 → 12/31/07

  Project: Research project

  • Interdisciplinary Research 100%
  • Rheumatology 49%
  • Arthritis 34%
  • Musculoskeletal Diseases 26%
  • Data Management 26%

• Prot# 016.0035: Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 2)

  Ruderman, E. M.

  Immunex Corporation

  10/29/02 → 12/1/07

  Project: Research project

• Functional Limitation, Arthritis, Depression, and Race

  Dunlop, D. D. & Chang, R. W.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  12/1/03 → 11/30/07

  Project: Research project

  • functional impairment 100%
  • medical rehabilitation 67%
  • health 63%
  • retirement 44%
  • skin disease 36%

• The Effects of an Inhibitory Compound to Mcl-1 (GX15-070) on the Rheumatoid Arthritis in Animal Models.

  Pope, R. M.

  Gemin X Biotechnologies Inc.

  4/26/05 → 11/1/07

  Project: Research project

• Fellowship in Support of Advanced Training in Scleroderma

  Varga, J. & Hinchcliff, M. E.

  Karen Brown Scleroderma Foundation

  11/1/06 → 10/31/07

  Project: Research project

• Prot# WA18696B: Long-Term Extenstion Study of Safety During Treatment with Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies

  Ruderman, E. M.

  Hoffman-La Roche, Inc.

  7/3/07 → 10/3/07

  Project: Research project

• Intergovernmental Personnel Agreement for D. Dunlop: Hines Cooperative Studies Program Coordinating Center

  Dunlop, D. D.

  Edward Hines, Jr. VA Hospital

  1/1/07 → 9/30/07

  Project: Research project

• Genetic Risk Profile in Longitudinal SLE Cohorts

  Ramsey-Goldman, R.

  University of Alabama at Birmingham, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/24/02 → 8/31/07

  Project: Research project

• Intergovernmental Personnel Agreement for D. Dunlop: NSAID-Related Adverse Events: Evaluating Risk Using Clinical Information

  Dunlop, D. D.

  Edward Hines, Jr. VA Hospital

  1/1/07 → 7/31/07

  Project: Research project

• Strength, Laxity, and Position Sense in OA Progression

  Sharma, L. & Dunlop, D. D.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/02 → 7/31/07

  Project: Research project

  • disability 100%
  • applicant 66%
  • infrastructure 50%
  • costs 40%
  • history 38%

• Progression of Knee OA: The Role of Local Factors

  Sharma, L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  3/6/02 → 6/30/07

  Project: Research project

  • Knee Osteoarthritis 100%
  • Osteoarthritis 59%
  • Cartilage 44%
  • Proprioception 42%
  • Tears 32%

• LCTC Network Participation - To Identify Promising New Therapies for Systemic Lupus Erythematosus and to Encourage Testing of those Therapies by Clinical Trial Sponsors

  Ramsey-Goldman, R.

  Lupus Clinical Trials Consortium

  1/15/04 → 6/30/07

  Project: Research project

• Revision of ACR Classification/Diagnostic Criteria for SLE

  Ramsey-Goldman, R.

  Johns Hopkins University, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/04 → 6/30/07

  Project: Research project

  • Systemic Lupus Erythematosus 100%
  • Rheumatology 82%
  • Clinical Trials 32%
  • Climate 18%
  • Psychotic Disorders 15%

• Prot# WA17043/U2644g: A Randomized, Multifactorial, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of Rituximab (Mabthera®/Rituxan®) In Combination with Methotrexate in Patients with Active Rheumatoid Arthritis

  Ruderman, E. M.

  Genentech, Inc.

  7/11/03 → 6/1/07

  Project: Research project

• CAREER: Interleukin-18 in Inflammation and Angiogenesis

  Pope, R. M.

  National Institute of Allergy and Infectious Diseases

  9/30/01 → 5/31/07

  Project: Research project

  • Interleukin-18 100%
  • Inflammation 33%
  • Rheumatoid Arthritis 21%
  • Cytokines 16%
  • Fibroblasts 7%

• Prot# LBRA01: A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects with Rheumatoid Arthritis (RA)

  Ruderman, E. M.

  Human Genome Sciences, Inc.

  1/15/04 → 5/24/07

  Project: Research project

• Prot# C0168T34: The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol -- Tapering Methotrexate in Patients with Rheumatoid Arthritis Beginning Therapy with Infliximab

  Ruderman, E. M.

  Kendle International Inc., Centocor, Inc.

  4/15/02 → 5/24/07

  Project: Research project

• Prot# 2315IL/0004: An Open, Mulicentre, Long-Term Follow-Up Study to Assess the Safety of Patients who Complete or Discontinue Early from Treatment in Any Study Involving ZD2315 (Study Code #SC-315-5261)

  Ruderman, E. M.

  AstraZeneca LP

  11/14/01 → 5/24/07

  Project: Research project

• Prot# N49-02-12-202: REVISED Protocol for a Double-Blind, Placebo-Controlled, Randomized Comparison of the Efficacy and Safety of Celecoxib 200mg and Celecoxib 400mg QD in Treating the Signs and Symptoms of Psoriatic Arthritis

  Ruderman, E. M.

  Pharmacia & Upjohn, Inc.

  9/24/02 → 5/21/07

  Project: Research project

• Prot#ABX-0206: A Multi-center, Placebo-Controlled, Parallel-Group Double-Blind Study to Assess the Safety and Efficacy of ABX-IL8 in Rheumatoid Arthritis Patients

  Ruderman, E. M.

  Abgenix, Inc.

  5/25/01 → 4/10/07

  Project: Research project

• Exposure to Immunosuppressive Drugs and Cancer Risk in SLE

  Ramsey-Goldman, R.

  National Cancer Institute

  9/8/04 → 2/28/07

  Project: Research project

  • Systemic Lupus Erythematosus 100%
  • Immunosuppressive Agents 56%
  • Neoplasms 37%
  • Pharmaceutical Preparations 28%
  • Cohort Studies 27%

• Prot# 15201: Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of TRU-015 Administered Intravenously in Subjects with Idiopathic Inflammatory Myopathy (Polymyositis and Dermatomyositis)

  Ruderman, E. M.

  Trubion Pharmaceuticals Inc.

  11/30/05 → 1/4/07

  Project: Research project

• Multidisciplinary Clinical Research Center in Rheumatology: Project 4 - Development and Feasibility

  Pope, R. M.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/15/02 → 12/31/06

  Project: Research project

  • Interdisciplinary Research 100%
  • Rheumatology 49%
  • Arthritis 34%
  • Musculoskeletal Diseases 26%
  • Data Management 26%

• Inflammatory Markers in Cardiovascular Disease (CVD) and Osteoporosis (OP) in Systemic Lupus Erythematosus Women

  Ramsey-Goldman, R.

  Northwestern Memorial Foundation

  1/1/05 → 12/31/06

  Project: Research project